Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2009 (2009), Article ID 794935, 3 pages
http://dx.doi.org/10.1155/2009/794935
Case Report

Severe Keratitis Caused by Pseudomonas aeruginosa Successfully Treated with Ceftazidime Associated with Acetazolamide

1Department of Pharmacy, Pharmacology, and Toxicology, Hotel-Dieu, 1 Place Notre-Dame, 75004 Paris, France
2Department of Ophthalmology, Hotel-Dieu, 1 Place Notre-Dame, 75004 Paris, France

Received 18 February 2009; Accepted 2 April 2009

Academic Editor: David Wilkie

Copyright © 2009 Benoit Hue et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Voutsinas, E. Kavouklis, D. Voutsinas, K. Kontoghiorgi, and H. Giamarellou, “The effect of acetazolamide on the kinetics of four newer β-lactams in the aqueous humor,” Clinical Microbiology and Infection, vol. 7, no. 2, pp. 70–74, 2001. View at Publisher · View at Google Scholar
  2. J. H. Mah-Sadorra, S. G. A. Yavuz, D. M. Najjar, P. R. Laibson, C. J. Rapuano, and E. J. Cohen, “Trends in contact lens-related corneal ulcers,” Cornea, vol. 24, no. 1, pp. 51–58, 2005. View at Publisher · View at Google Scholar
  3. M. M. Schornack, L. J. Faia, and G. J. Griepentrog, “Pseudomonas keratitis associated with daily wear of silicone hydrogel contact lenses,” Eye & Contact Lens, vol. 34, no. 2, pp. 124–128, 2008. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Green, A. Apel, and F. Stapleton, “Risk factors and causative organisms in microbial keratitis,” Cornea, vol. 27, no. 1, pp. 22–27, 2008. View at Publisher · View at Google Scholar · View at PubMed
  5. D. M. Najjar, S. G. Aktan, C. J. Rapuano, P. R. Laibson, and E. J. Cohen, “Contact lens-related corneal ulcers in compliant patients,” American Journal of Ophthalmology, vol. 137, no. 1, pp. 170–172, 2004. View at Publisher · View at Google Scholar
  6. R. W. Snyder and D. B. Glasser, “Antibiotic therapy for ocular infection,” Western Journal of Medicine, vol. 161, no. 6, pp. 579–584, 1994. View at Google Scholar
  7. American Academy of Ophthalmology, “Bacterial Keratitis,” Preferred Practice Pattern, San Francisco, Calif, USA, 2005.
  8. R. A. Walstad, K. B. Hellum, S. Blika et al., “Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid,” Journal of Antimicrobial Chemotherapy, vol. 12, pp. 275–282, 1983. View at Google Scholar
  9. V. Chédru-Legros, M. Fines-Guyon, A. Chérel et al., “Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at -20C,” Journal Francais d'Ophtalmologie, vol. 30, no. 8, pp. 807–813, 2007. View at Publisher · View at Google Scholar
  10. M. Manduru, L. B. Mihm, R. L. White, L. V. Friedrich, P. A. Flume, and J. A. Bosso, “In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 9, pp. 2053–2056, 1997. View at Google Scholar
  11. R. D. Schoenwald, G. S. Deshpande, D. G. Rethwisch, and C. F. Barfknecht, “Penetration into the anterior chamber via the conjunctival/scleral pathway,” Journal of Ocular Pharmacology and Therapeutics, vol. 13, no. 1, pp. 41–59, 1997. View at Publisher · View at Google Scholar